Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme (ICE) inhibitors

Bioorg Med Chem. 2006 Dec 1;14(23):7880-92. doi: 10.1016/j.bmc.2006.07.056.

Abstract

An 8,5-fused bicyclic peptidomimetic ring system generated by a stereoselective ring metathesis reaction was elaborated into potent inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1). Multiple compounds were found that exhibited ICE IC50 values < 10 nM and were selective over caspase-3 and caspase-8. These active analogs generally possessed good activity (IC50 values < 100 nM) in a whole cell assay measuring IL-1beta production. Pharmacokinetic analysis of the ethyl acetal prodrug form of a selected active lead revealed a compound with a reasonable plasma half-life (1.1 h) and good oral bioavailability (30%).

MeSH terms

  • Animals
  • Biological Availability
  • Bridged Bicyclo Compounds, Heterocyclic / chemical synthesis
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
  • Caspase Inhibitors*
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / pharmacology
  • Half-Life
  • Inhibitory Concentration 50
  • Molecular Mimicry
  • Peptides, Cyclic / chemical synthesis
  • Peptides, Cyclic / pharmacology*
  • Prodrugs / pharmacokinetics
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Caspase Inhibitors
  • Enzyme Inhibitors
  • Peptides, Cyclic
  • Prodrugs